lucas-vasques-9vnACvX2748-unsplash.jpg
lucas-vasques-9vnACvX2748-unsplash.jpg

Native Antigen Customisation

Customisation to meet your unique needs

BBI can support a range of different customisation options to support a client’s requirements. As a primary manufacturer we can support requests to adapt current products  to meet specific requirements, ranging from dispensation volumes, concentrations and alternative formulations or analytical testing methodologies. Native products are sourced from ethical, stable raw material suppliers.  

A UK government human tissue authority licenced site, BBI can, with sufficient notice, supply material from a broad range of human tissues and fluids from its extensive worldwide supply chain. Where BBI does not have a current, qualified off-the shelf biomarker to meet a specific need, BBI can source and purify the product to a bespoke specification. This process involves an in-depth discussion with our technical teams, followed by the generation of a custom proposal which defines the project including  timelines and costs. 

Please contact our Customer Services Team directly to discuss your requirements on tel:+44 (0) 1495 363000 or alternatively you can submit an enquiry here.

Technical Documents

There are currently no documents in this category.
There are currently no documents in this category.
There are currently no documents in this category.
There are currently no documents in this category.
There are currently no documents in this category.
There are currently no documents in this category.
There are currently no documents in this category.
There are currently no documents in this category.

Request a callback

BBI Solutions Brands

diarect.png

The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.

mbs.png

Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.

Newsletter

Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox